Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why Novocure Stock Was Sick Today

TheMotleyFool 
0 0 26.10.23
Why Novocure Stock Was Sick Today: https://g.foolcdn.com/editorial/images/752492/two-people-seated-at-a-lab-desk-featuring-a-pc-screen-and-microscope.jpg
 

Oncology-focused healthcare company  (NASDAQ: NVCR) wasn't much of a cure for anyone's ill finances on Thursday. Its share price dived by nearly 8% on the day after management released its latest set of quarterly results. That decline was notably steeper than the 1.2% dip of the benchmark S 500 index.

For its third quarter, Novocure collected total revenue of slightly over $127 million. That represented a year-over-year decline of 3%, and missed the consensus analyst estimate of almost $129 million.

As for the bottom line, the healthcare company's net loss amounted to $49.5 million, or $0.46 per share. While this bettered the average prognosticator forecast of a $0.53-per-share loss, it was nearly double the $26.6 million shortfall in the same quarter of 2022.

Continue reading


Source Fool.com

Novocure Ltd Stock

€21.05
0.460%
The Novocure Ltd stock is trending slightly upwards today, with an increase of €0.10 (0.460%) compared to yesterday's price.

Show more
Like: 0
NVCR
Share

Comments

Not a member yet? Sign up for free!